| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue | 39,664 | 32,928 | 25,797 | | Cost of Revenue | 13,313 | 10,710 | 6,743 | | | Gross Profit | 26,351 | 22,218 | 19,054 | | | Operating Expenses | | Research Development | 6,069 | 4,890 | 4,948 | | Selling General and Administrative | 21,538 | 20,532 | 15,485 | | Non Recurring | 252 |
-
|
-
| | Others | 1,651 | 1,541 | 1,001 | | | | Total Operating Expenses | 29,510 |
-
|
-
| | | | Operating Income or Loss | (3,159) | (4,745) | (2,380) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 651 | 1,483 | 1,808 | | Earnings Before Interest And Taxes | (2,508) | (3,262) | (572) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (2,508) | (3,262) | (572) | | Income Tax Expense | (356) | 1,011 | 117 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,152) | (4,273) | (689) | | | Non-recurring Events | | Discontinued Operations | 920 |
-
| (1,478) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (1,232) | (4,273) | (2,167) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,232) | ($4,273) | ($2,167) |
|
0.83% Nasdaq 
Income Statement
